Workspace 03 · Diagnostics, Imaging & Digital Biomarkers

Diagnostic AI must make uncertainty visible before it shapes interpretation.

This workspace reads AI across imaging, pathology, signal detection, digital biomarkers, wearables, endpoint support, and laboratory interpretation where evidence, performance, bias, and intended use determine trust.

Focus: signal · interpretation · evidenceRisk: hidden error and subgroup failureBridge: data quality · validation · monitoring
Diagnostics traceSignalLabelModelReaderEndpointReviewAIsystemsource to workflow to evidence to review
AI in Healthcare/Diagnostics, Imaging & Digital Biomarkers
/ workspace

Diagnostics, Imaging & Digital Biomarkers workspace.

9 chapter surfaces

This workspace reads AI across imaging, pathology, signal detection, digital biomarkers, wearables, endpoint support, and laboratory interpretation where evidence, performance, bias, and intended use determine trust.

/ map

Source-to-use operating map.

how this workspace reads AI
Operating map
InventoryList the AI systems, actors, records, and workflows in scope.
RiskClassify impact, uncertainty, affected users, and plausible harms.
EvidenceConnect claims to validation, source data, limitations, and monitoring.
ReviewKeep owners, decisions, revisions, and open questions visible.
Chapter 01

Overview

The overview defines the boundary of Diagnostics, Imaging & Digital Biomarkers: what belongs in scope, what remains outside the claim, and what evidence has to travel with any public or operational interpretation.

source-backedRead →
Chapter 02

Use Cases

Use cases in Diagnostics are sorted by the decision they affect and the evidence they require, not by the attractiveness of the tool demonstration.

source-backedRead →
Chapter 03

Data Substrate

The data substrate for Diagnostics determines what the model can know, what it misses, what it amplifies, and what remains reviewable later.

source-backedRead →
Chapter 04

Model Lifecycle

The lifecycle view treats AI in Diagnostics as a managed capability: design, validation, deployment, monitoring, update, rollback, and retirement.

source-backedRead →
Chapter 05

Validation & Evidence

Validation evidence for Diagnostics connects technical performance to the real workflow, population, user, and decision context.

source-backedRead →
Chapter 06

Governance & Risk

Governance and risk for Diagnostics define who can approve use, what harms are plausible, which controls apply, and when use is paused or escalated.

source-backedRead →
Chapter 07

Operations & Adoption

Operations and adoption in Diagnostics focus on whether teams can use the system consistently, challenge it safely, and learn from real use.

source-backedRead →
Chapter 08

Market & Actors

The market and actor layer for Diagnostics maps who builds, sells, deploys, uses, monitors, audits, and regulates the capability.

source-backedRead →
Chapter 09

Updates & Assets

The updates and assets layer keeps Diagnostics alive through weekly signals, source maps, checklists, explainers, and revision notes.

source-backedRead →
/ sources

Source anchors and claim boundary.

official first

These anchors support the source layer for this workspace. iFeed interpretation stays separate from source facts and does not replace legal, regulatory, clinical, or product-specific advice.